A recent study by Crassini et al. showed that locostatin, an inhibitor of RKIP, downregulates phosphorylation of MAPK-ERK1/2 and AKT and induces apoptosis of chronic lymphocytic leukemia (CLL) cells [55]. The gene discussed is MAPK3; the disease is B-cell chronic lymphocytic leukemia.